MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Imaging Tau in Atypical Parkinsonisms: Meta-Analysis of in vivo PET Imaging Findings

    A. Mena, A. Strafella (Toronto, Canada)

    Objective: To determine the most accurate and reliable tau PET tracers for providing differential diagnosis of PSP and CBD from PD. Background: Parkinsonism is classified…
  • 2022 International Congress

    SARS-CoV-2 Infection and Spinocerebellar Ataxia 12: Demographics, Outcomes and Post- COVID Spectrum

    IS. Singh, VS. Swarup, AKS. Srivastava (New Delhi, India)

    Objective: We aimed to assess the symptoms and long-term symptoms in spinocerebellar ataxia 12 (SCA12) COVID-19 patients. Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
  • 2022 International Congress

    Aberrant visual-related networks in familial cortical myoclonic tremor with epilepsy

    H. Wang, B. Wang, Z. Cen, J. Wang, Y. Zang, D. Yang, Y. Ding, S. Wang, S. Wu, W. Luo (Hangzhou, China)

    Objective: To explore the mechanism of prominent visual-related symptoms and photosensitivity, and to investigate alterations of local brain activity and visual-related networks using resting-state functional magnetic…
  • 2022 International Congress

    Long-term efficacy of unilateral high-intensity focused ultrasound subthalamotomy for Parkinson’s Disease

    R. Martínez-Fernández, E. Natera-Villalba, J. Máñez-Miró, R. Rodríguez-Rojas, M. Del Alamo, J. Pineda-Pardo, I. Obeso, F. Hernández-Fernández, C. Gasca-Salas, M. Matarazzo, L. Vela, F. Alonso-Frech, J. Obeso (Móstoles, Madrid, Spain)

    Objective: To explore the long-term safety and efficacy of focused ultrasound subthalamotomy (FUS-STN). Background: Unilateral MRI-guided high-intensity FUS-STN improves motor signs of Parkinson’s disease (PD) [1]…
  • 2022 International Congress

    Mindfulness based program for newly diagnosed Parkinson’s patients.

    A. Shaji, A. Lasker, N. Ko, M. Solanki, P. Kaur, Y. Ocasio, C. Fanning (Bethlehem, USA)

    Objective: To investigate the impact of 8-week course of Mindfulness based intervention program on motor and or non-motor symptoms of PD assessed by improvement in…
  • 2022 International Congress

    Optimizing patient-centric clinical outcome assessments for use in Parkinson’s disease clinical trials: Critical Path for Parkinson’s multistakeholder initiative

    R. Speck, D. Trundell, J. Cedarbaum, M. Campbell, P. Chin, S. Crawford, T. Dam, D. Dexter, A. Goldfine, K. Klapper, C. Kopil, S. Lee, K. Marek, H. Matthews, T. Mestre, T. Morel, M. Minchik, M. Müller, K. Schroeder, T. Simuni, G. Stebbins, C. Yan, ML. Zeissler, D. Stephenson (Tucson, USA)

    Objective: To advance patient-centric endpoints for use in early-stage Parkinson’s disease (PD) clinical trials. Background: Limitations with currently available patient-centric clinical outcome assessments (COAs) has…
  • 2022 International Congress

    Milder presentation in two compound heterozygote cases of spastic paraplegias type 5

    A. Zolin, S. Lakhani, H. Sarva (New York, USA)

    Objective: Describing two mild compound heterozygote SPG5A cases. Background: Hereditary spastic paraplegia type 5 (SPG5A) is an autosomal recessive neurodegenerative disease caused by variants in…
  • 2022 International Congress

    Factors related to the antidepressant effect of safinamide in Parkinson’s disease. A post-hoc analysis of SADNESS-PD study

    E. Peña, C. Borrué, M. Mata, JC. Martínez-Castrillo, A. Alonso-Canovas, JL. Chico, L. López-Manzanares, M. Llanero, J. Herreros-Rodríguez, A. Esquivel, T. Maycas-Cepeda, C. Ruíz-Huete (Madrid, Spain)

    Objective: To assess the role of different factors in the antidepressant effect of safinamide in Parkinson’s disease (PD) Background: SADNESS-PD was a real-life, multicenter, retrospective…
  • 2022 International Congress

    Apathy and Volume of Tissue Activated (VTA) following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Cohort

    T. Stiep, A. Ramirez-Zamora, J. Wong, A. Tröster, R. Jain, L. Chen, M. Malek, M. Okun (Gainesville, USA)

    Objective: To determine frequency and/or predictors of improvement or worsening of apathy, we evaluated this behavior among those who received bilateral subthalamic deep brain stimulation…
  • 2022 International Congress

    Metabolic Biomarkers of Parkinson’s Disease in Peripheral Tissue

    L. Mischley, E. Shankland, S. Liu, S. Bhayana, D. Marcinek (Seattle, USA)

    Objective: The goal of this study was to use magnetic resonance spectroscopy (MRS) to test whether muscles of individuals with Parkinson’s disease (PD) possess a…
  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley